Insider Trading Alert - MSCC, DLX, BRE, UMBF And OPK Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Friday, Nov. 22, 2013, 166 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $98.40 to $54,600,947.10.

Highlighted Stocks Traded by Insiders:

Microsemi (MSCC) - FREE Research Report

Folino Paul F who is Director at Microsemi bought 1,100 shares at $23.16 on Nov. 22, 2013. Following this transaction, the Director owned 1,100 shares meaning that the stake was reduced by 100% with the 1,100 share transaction.

The shares most recently traded at $23.99, up $0.83, or 3.46% since the insider transaction. Historical insider transactions for Microsemi go as follows:

  • 4-Week # shares sold: 112,001
  • 12-Week # shares sold: 392,935
  • 24-Week # shares sold: 394,935

The average volume for Microsemi has been 497,500 shares per day over the past 30 days. Microsemi has a market cap of $2.2 billion and is part of the technology sector and electronics industry. Shares are up 12.83% year to date as of the close of trading on Friday.

Microsemi Corporation designs, manufactures, and markets analog and mixed-signal semiconductor solutions primarily in the United States, Europe, and Asia. The company has a P/E ratio of 48.8. Currently there are 4 analysts that rate Microsemi a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on MSCC - FREE

TheStreet Quant Ratings rates Microsemi as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, compelling growth in net income, notable return on equity, expanding profit margins and largely solid financial position with reasonable debt levels by most measures. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full Microsemi Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Deluxe Corporation (DLX) - FREE Research Report

Metviner Neil who is Director at Deluxe Corporation sold 4,000 shares at $48.72 on Nov. 22, 2013. Following this transaction, the Director owned 17,002 shares meaning that the stake was reduced by 19.05% with the 4,000 share transaction.

The shares most recently traded at $49.13, up $0.41, or 0.83% since the insider transaction. Historical insider transactions for Deluxe Corporation go as follows:

  • 4-Week # shares sold: 25,500
  • 12-Week # shares sold: 25,500
  • 24-Week # shares sold: 34,938

The average volume for Deluxe Corporation has been 338,900 shares per day over the past 30 days. Deluxe Corporation has a market cap of $2.5 billion and is part of the services sector and diversified services industry. Shares are up 51.49% year to date as of the close of trading on Friday.

Deluxe Corporation, together with its subsidiaries, provides printed products, forms, and marketing solutions to small businesses and financial institutions primarily in the United States, Canada, Europe, and South America. The stock currently has a dividend yield of 2.04%. The company has a P/E ratio of 13.7. Currently there is 1 analyst that rates Deluxe Corporation a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on DLX - FREE

TheStreet Quant Ratings rates Deluxe Corporation as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, growth in earnings per share, attractive valuation levels and good cash flow from operations. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full Deluxe Corporation Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

BRE Properties (BRE) - FREE Research Report

Fanwick Kerry who is EVP, General Counsel at BRE Properties sold 1,000 shares at $52.13 on Nov. 22, 2013. Following this transaction, the EVP, General Counsel owned 58,240 shares meaning that the stake was reduced by 1.69% with the 1,000 share transaction.

The shares most recently traded at $51.50, down $0.63, or 1.22% since the insider transaction. Historical insider transactions for BRE Properties go as follows:

  • 4-Week # shares sold: 500
  • 12-Week # shares sold: 2,500
  • 24-Week # shares sold: 7,500

The average volume for BRE Properties has been 559,500 shares per day over the past 30 days. BRE Properties has a market cap of $4.0 billion and is part of the financial sector and real estate industry. Shares are up 2.3% year to date as of the close of trading on Friday.

BRE Properties Inc. is an independent real estate investment trust. The firm invests in the real estate markets of the United States. It focuses on the development, acquisition, and management of multifamily apartment communities. BRE Properties Inc. The stock currently has a dividend yield of 3.04%. The company has a P/E ratio of 24.0. Currently there are 2 analysts that rate BRE Properties a buy, 2 analysts rate it a sell, and 7 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on BRE - FREE

TheStreet Quant Ratings rates BRE Properties as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, good cash flow from operations, compelling growth in net income, notable return on equity and increase in stock price during the past year. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full BRE Properties Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

UMB Financial Corporation (UMBF) - FREE Research Report

Rilinger Dennis R who is EVP and General Counsel at UMB Financial Corporation sold 1,907 shares at $63.01 on Nov. 22, 2013. Following this transaction, the EVP and General Counsel owned 15,565 shares meaning that the stake was reduced by 10.91% with the 1,907 share transaction.

Desilva Peter J who is President and COO at UMB Financial Corporation sold 1,477 shares at $61.57 on Nov. 22, 2013. Following this transaction, the President and COO owned 0 shares meaning that the stake was reduced by 100% with the 1,477 share transaction.

The shares most recently traded at $63.80, up $2.23, or 3.5% since the insider transaction. Historical insider transactions for UMB Financial Corporation go as follows:

  • 4-Week # shares sold: 2,241
  • 12-Week # shares sold: 2,741
  • 24-Week # shares bought: 128
  • 24-Week # shares sold: 16,033

The average volume for UMB Financial Corporation has been 273,600 shares per day over the past 30 days. UMB Financial Corporation has a market cap of $2.9 billion and is part of the financial sector and banking industry. Shares are up 44.18% year to date as of the close of trading on Friday.

UMB Financial Corporation, through its subsidiaries, offers various banking and other financial services in the United States. The company operates through four segments: Bank, Payment Solutions, Institutional Investment Management, and Asset Servicing. The stock currently has a dividend yield of 1.42%. The company has a P/E ratio of 21.3. Currently there is 1 analyst that rates UMB Financial Corporation a buy, no analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on UMBF - FREE

TheStreet Quant Ratings rates UMB Financial Corporation as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, growth in earnings per share, increase in net income, solid stock price performance and expanding profit margins. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full UMB Financial Corporation Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Opko Health (OPK) - FREE Research Report

Frost Phillip Md Et Al who is CEO & Chairman at Opko Health bought 33,400 shares at $10.04 on Nov. 22, 2013. Following this transaction, the CEO & Chairman owned 137.2 million shares meaning that the stake was reduced by 0.02% with the 33,400 share transaction.

The shares most recently traded at $9.98, down $0.06, or 0.56% since the insider transaction.

The average volume for Opko Health has been 5.1 million shares per day over the past 30 days. Opko Health has a market cap of $4.1 billion and is part of the health care sector and health services industry. Shares are up 107.69% year to date as of the close of trading on Friday.

Opko Health, Inc., a pharmaceutical and diagnostics company, engages in the discovery, development, and commercialization of novel and proprietary technologies. It operates in two segments, Pharmaceuticals and Diagnostics. Currently there are 3 analysts that rate Opko Health a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on OPK - FREE

TheStreet Quant Ratings rates Opko Health as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. However, as a counter to these strengths, we also find weaknesses including feeble growth in the company's earnings per share, deteriorating net income and weak operating cash flow. Get the full Opko Health Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Data for this article provided by Zacks Investment Research

null

More from Markets

Global Stocks Ease as Investors Focus on Dollar, Oil, Italy After US-China Truce

Global Stocks Ease as Investors Focus on Dollar, Oil, Italy After US-China Truce

Replay: Jim Cramer on Tariffs, the Market Rally, Caterpillar and Micron

Replay: Jim Cramer on Tariffs, the Market Rally, Caterpillar and Micron

Video: When Planning for Retirement, Don't Underestimate Your Life Span

Video: When Planning for Retirement, Don't Underestimate Your Life Span

Video: Here's What May Come Next for Theranos Founder and CEO Elizabeth Holmes

Video: Here's What May Come Next for Theranos Founder and CEO Elizabeth Holmes

Charlie Gasparino Says GE Is Reportedly Looking to Slash Its Dividend Again

Charlie Gasparino Says GE Is Reportedly Looking to Slash Its Dividend Again